Publicacións en colaboración con investigadores/as de Instituto de Salud Musculoesquelética (141)

2024

  1. SLESIS-R: an improved score for prediction of serious infection in patients with systemic lupus erythematosus based on the RELESSER prospective cohort

    Lupus Science and Medicine, Vol. 11, Núm. 1

  2. Tumor-induced osteomalacia: A systematic literature review

    Bone Reports, Vol. 21

2023

  1. Association Between Race/Ethnicity and COVID-19 Outcomes in Systemic Lupus Erythematosus Patients From the United States: Data From the COVID-19 Global Rheumatology Alliance

    Arthritis Care and Research, Vol. 75, Núm. 1, pp. 53-60

  2. Patient perspectives on long-term outcomes in rheumatoid arthritis. A qualitative study from the OMERACT patient outcomes in longitudinal studies working group

    Seminars in Arthritis and Rheumatism, Vol. 58

  3. Proposal for updating the Health Assessment Questionnaire

    Reumatologia Clinica, Vol. 19, Núm. 5, pp. 266-272

  4. Response to: 'Correspondence on 'Factors associated with COVID-19-related death in people with rheumatic diseases: Results from the COVID-19 Global Rheumatology Alliance physician reported registry' by Arnaud and Devilliers

    Annals of the Rheumatic Diseases

  5. Response to: 'Correspondence on 'Factors associated with COVID-19-related death in people with rheumatic diseases: Results from the COVID-19 Global Rheumatology Alliance physician reported registry'' by Mulhearn et al

    Annals of the Rheumatic Diseases

  6. Response to: 'Correspondence on 'Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician reported registry'' by Rosenbaum et al

    Annals of the Rheumatic Diseases

  7. What do patients on methotrexate need and expect at the clinic? An online patient survey

    Rheumatology International, Vol. 43, Núm. 4, pp. 735-741

2022

  1. Characteristics and Outcomes of People With Gout Hospitalized Due to COVID-19: Data From the COVID-19 Global Rheumatology Alliance Physician-Reported Registry

    ACR Open Rheumatology, Vol. 4, Núm. 11, pp. 948-953

  2. Characteristics associated with poor COVID-19 outcomes in individuals with systemic lupus erythematosus: data from the COVID-19 Global Rheumatology Alliance

    Annals of the rheumatic diseases, Vol. 81, Núm. 7, pp. 970-978

  3. Developing guidelines for ultrarare rheumatic disorders: A bumpy ride

    Annals of the Rheumatic Diseases, Vol. 81, Núm. 9, pp. 1203-1205

  4. Development and external validation of prediction models for adverse health outcomes in rheumatoid arthritis: A multinational real-world cohort analysis

    Seminars in Arthritis and Rheumatism, Vol. 56

  5. Development of a Prediction Model for COVID-19 Acute Respiratory Distress Syndrome in Patients With Rheumatic Diseases: Results From the Global Rheumatology Alliance Registry

    ACR Open Rheumatology, Vol. 4, Núm. 10, pp. 872-882

  6. Environmental and societal factors associated with COVID-19-related death in people with rheumatic disease: an observational study

    The Lancet Rheumatology, Vol. 4, Núm. 9, pp. e603-e613

  7. Implementation of recommendations in rheumatic and musculoskeletal diseases: considerations for development and uptake

    Annals of the Rheumatic Diseases, Vol. 81, Núm. 10, pp. 1344-1347

  8. Interobserver reliability of Masei index validation by a multicenter collaborative group of rheumatologists

    Rheumatology International, Vol. 42, Núm. 3, pp. 441-448

  9. Intra-articular therapies: patient preferences and professional practices in European countries

    Rheumatology International, Vol. 42, Núm. 5, pp. 869-878

  10. More, none, less therapeutic effect? Should we start talking about a 'lessebo' effect?

    Rheumatology (United Kingdom)

  11. Multilevel factors predict medication adherence in rheumatoid arthritis: a 6-month cohort study

    Annals of the rheumatic diseases, Vol. 81, Núm. 3, pp. 327-334